A Study to Test if TEV-53275 is Effective in Relieving Asthma

NCT04847674 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

97

Enrollment

INDUSTRY

Sponsor class

Stopped Stopped for strategic reasons

Conditions

Asthma

Interventions

DRUG: TEV-53275 Dose A
DRUG: TEV-53275 Dose B
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.